menu
    • menu

    Company profile for InVivo Therapeutics

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    InVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. The company was founded in 2005 with proprietary technology co-invented by Robert Langer, Sc.D., Professor at Massachusetts Institute of Technology, and Joseph P. Vacanti, M.D., who then was at Boston Children’s Hospital and who now is affiliated with Massachusetts Gene...
    InVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. The company was founded in 2005 with proprietary technology co-invented by Robert Langer, Sc.D., Professor at Massachusetts Institute of Technology, and Joseph P. Vacanti, M.D., who then was at Boston Children’s Hospital and who now is affiliated with Massachusetts General Hospital. The publicly traded company is headquartered in Cambridge, MA.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    InVivo Therapeuticsunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    One Kendall Square, Building 1400 East, Floor 4, Cambridge
    Telephone
    Telephone
    (617) 863-5500
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.invivotherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Spanish VC preps launch for €100M fund with an emphasis on advanced therapies
    Spanish VC preps launch for €100M fund with an emphasis on advanced therapies

    06 Mar 2024

    // ENDPTS

    https://endpts.com/invivo-preps-launch-for-e100m-fund-with-an-emphasis-on-advanced-therapies/

    ENDPTS
    06 Mar 2024
    Share Share
    InVivo Therapeutics Announces Topline Data from Pivotal INSPIRE 2.0 Study
    InVivo Therapeutics Announces Topline Data from Pivotal INSPIRE 2.0 Study

    09 Mar 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230309005216/en

    BUSINESSWIRE
    09 Mar 2023
    Share Share
    InVivo Announces Closing of $9M Registered Direct & Private Placement Offerings
    InVivo Announces Closing of $9M Registered Direct & Private Placement Offerings

    11 Oct 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221011005236/en

    BUSINESSWIRE
    11 Oct 2022
    Share Share
    InVivo Announces $9M Registered Direct Placement Offerings Under Nasdaq Rules
    InVivo Announces $9M Registered Direct Placement Offerings Under Nasdaq Rules

    07 Oct 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221007005151/en

    BUSINESSWIRE
    07 Oct 2022
    Share Share
    What Is Going on With InVivo Therapeutics (NVIV) Stock Today?
    What Is Going on With InVivo Therapeutics (NVIV) Stock Today?

    03 Aug 2022

    // INVESTOR PLACE

    https://investorplace.com/2022/08/what-is-going-on-with-invivo-therapeutics-nviv-stock-today/

    INVESTOR PLACE
    03 Aug 2022
    Share Share
    InVivo Therapeutics Announces Reverse Stock Split
    InVivo Therapeutics Announces Reverse Stock Split

    14 Apr 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220414005611/en

    BUSINESSWIRE
    14 Apr 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search